Delisting riskPopularity #5,362
Reviva Pharmaceuticals (RVPH)
Develops brilaroxazine-led therapies for CNS, inflammatory, and cardiometabolic diseases.
$0.4800
vs last close−0.05 (−9.09%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.29
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$3.00−$2.60−$2.40−$1.20$0.72−$0.46−$0.19Pending
Estimate−$0.22−$3.94−$2.35−$1.89−$1.08−$0.75−$0.39−$0.29
Surprise−1,263.6%+34.0%−2.1%+36.7%+166.7%+38.7%+50.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.10 | — | — |
| Sep 2028 | −$0.09 | — | — |
| Jun 2028 | −$0.09 | — | — |
| Mar 2028 | −$0.09 | — | — |
| Dec 2027 | −$0.25 | — | — |
| Sep 2027 | −$0.23 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.19 | — | — |
| Dec 2026 | −$0.29 | — | — |
| Nov 2026 | −$0.29 | — | — |
| Aug 2026 | −$0.39 | −$0.19 | +50.6% |
| May 2026 | −$0.75 | −$0.46 | +38.7% |
| Mar 2026 | −$1.08 | $0.72 | +166.7% |
| Nov 2025 | −$1.89 | −$1.20 | +36.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Sep 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| May 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.10 | — | — | $48.3M | — | — | — |
| Sep 2028 | −$0.09 | — | — | $46.4M | — | — | — |
| Jun 2028 | −$0.09 | — | — | $46.4M | — | — | — |
| Mar 2028 | −$0.09 | — | — | $44.6M | — | — | — |
| Dec 2027 | −$0.25 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.23 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.18 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.19 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.29 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.29 | — | — | $0 | — | — | — |
| Aug 13, 2026 | −$0.39 | −$0.19 | +50.6% | — | — | — | +1.1% |
| May 14, 2026 | −$0.75 | −$0.46 | +38.7% | — | — | — | +10.8% |
| Mar 30, 2026 | −$1.08 | $0.72 | +166.7% | — | — | — | +10.6% |
| Nov 13, 2025 | −$1.89 | −$1.20 | +36.7% | — | — | — | −6.6% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 14, 2024 | |||||||
| Apr 15, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 22, 2021 | |||||||
| Jan 14, 2021 | |||||||
| Sep 14, 2020 | |||||||
| Jul 7, 2020 | |||||||
| May 2, 2020 | |||||||
| Jan 10, 2020 | |||||||
| Oct 8, 2019 | |||||||
| Jul 3, 2019 | |||||||
| May 22, 2019 | |||||||
| Jan 9, 2019 | |||||||
| Oct 11, 2018 | |||||||
| May 31, 2018 |